Walvax BioTech (300142) — Net Asset Momentum
Walvax BioTech (300142) recorded a net asset momentum of -14.7% as of December 2025, with net assets of CN¥9.81 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 300142 book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Walvax BioTech Net Asset Momentum (2007–2025)
This chart tracks Walvax BioTech's year-over-year net asset growth across 19 annual reporting periods from 2007 to 2025. The most recent momentum reading is -14.7%, with net assets of CN¥9.81 Billion CNY as of December 2025. For live market cap and overall valuation, see how much is Walvax BioTech worth.
Annual Net Asset History for Walvax BioTech (2007–2025)
The table below shows the complete annual net asset history for Walvax BioTech from 2007 to 2025, covering 19 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Walvax BioTech tangible equity quality to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥9.81 Billion | CN¥12.07 Billion | CN¥2.26 Billion | ▼ -14.7% |
| 2024 | CN¥11.51 Billion | CN¥14.72 Billion | CN¥3.22 Billion | ▲ +1.0% |
| 2023 | CN¥11.40 Billion | CN¥15.59 Billion | CN¥4.19 Billion | ▲ +3.7% |
| 2022 | CN¥10.99 Billion | CN¥15.34 Billion | CN¥4.35 Billion | ▲ +9.9% |
| 2021 | CN¥10.00 Billion | CN¥13.67 Billion | CN¥3.68 Billion | ▲ +27.4% |
| 2020 | CN¥7.85 Billion | CN¥9.65 Billion | CN¥1.80 Billion | ▲ +38.5% |
| 2019 | CN¥5.67 Billion | CN¥7.02 Billion | CN¥1.35 Billion | ▲ +7.7% |
| 2018 | CN¥5.26 Billion | CN¥7.24 Billion | CN¥1.98 Billion | ▲ +47.9% |
| 2017 | CN¥3.56 Billion | CN¥5.88 Billion | CN¥2.32 Billion | ▲ +1.0% |
| 2016 | CN¥3.52 Billion | CN¥6.32 Billion | CN¥2.80 Billion | ▲ +16.5% |
| 2015 | CN¥3.02 Billion | CN¥6.26 Billion | CN¥3.23 Billion | ▼ -5.9% |
| 2014 | CN¥3.21 Billion | CN¥5.97 Billion | CN¥2.76 Billion | ▲ +9.3% |
| 2013 | CN¥2.94 Billion | CN¥6.14 Billion | CN¥3.20 Billion | ▼ -7.3% |
| 2012 | CN¥3.17 Billion | CN¥4.45 Billion | CN¥1.28 Billion | ▲ +16.8% |
| 2011 | CN¥2.71 Billion | CN¥3.01 Billion | CN¥293.62 Million | ▲ +6.4% |
| 2010 | CN¥2.55 Billion | CN¥2.99 Billion | CN¥435.52 Million | ▲ +1360.3% |
| 2009 | CN¥174.69 Million | CN¥386.12 Million | CN¥211.43 Million | ▲ +77.6% |
| 2008 | CN¥98.36 Million | CN¥301.90 Million | CN¥203.54 Million | ▲ +457.1% |
| 2007 | CN¥17.66 Million | CN¥217.52 Million | CN¥199.86 Million | — |